Insulin treatment of women with GDM (i.e., patients under insulin therapy) reverses the GDM-associated maternal and foetal hyperglycaemia and the increase in IRS-1 and PI3K p85α activity caused by this disease to values in normal pregnancies [90]. The gene discussed is INS; the disease is Hyperglycemia.